Recurrence of oropharyngeal carcinoma. A retrospective study of 207 patients.

We analyzed 32 cases of lateral wall oropharyngeal carcinoma treated at our institution retrospectively. Fiveyear overall and disease-specific survival rates were 50% and 62%, respectively. The 5-year locoregional control rate was 57%, and including salvage therapy it was improved up to 62%. It was difficult to control locoregional tumor with surgery in far-advanced cases where the tumor had invaded the nasopharynx or larynx. There is a possibility of salvage if the recurrence is solitary, but a case with multiple recurrence is difficult to salvage.

show abstract

Clinical outcome of patients with oropharyngeal squamous cell carcinoma

Ebisumoto¹,

Okami²,

Sakai³

et al. 2011

Toukeibu Gan

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Recurrence of oropharyngeal carcinoma. A retrospective study of 207 patients.

Cited by 3 publications

References 4 publications

Strategies for Oropharyngeal Cancer

Strategies for Oropharyngeal Cancer

Clinical analysis of lateral wall oropharyngeal carcinoma-A retrospective study of 32 cases

Clinical outcome of patients with oropharyngeal squamous cell carcinoma

Contact Info

Product

Resources

About